THE ONLY ANTI-BIOFILM SILVER DRESSING THAT PROVIDES COMPLETE & CONTINUOUS CLEANING ACTION IN THE WOUND
For wounds at risk or with signs of local infection, from the debridement stage
Fast and effective antimicrobial action5
Destroys, removes and prevents biofilm reappearance1, 5
Complete and continuous cleaning action to remove slough exudate and bacterial residues6, 11
Clinically proven complete cleaning action
- UrgoCleanAg provides complete and continuous cleaning action due to its polyabsorbent fibres
- 75% reduction in the number of wounds with heavy exudate
- 62.5% reduction of sloughy tissue and wound debris
- Continuous cleaning action sustained for up to 7 days
- The powerful combined cleaning and antimicrobial actiondestroys, removes biofilms and blocks their reformation for up to 7 days
- UrgoClean Ag reduces 99.99% biofilms population in just 24h1
UrgoClean Ag
A sterile, non-woven pad composed of hydro-desloughing, polyabsorbent fibres coated with TLC‑Ag
FEATURES
| FEATURES | BENEFITS |
|---|---|
Fast and effective anti-biofilm action |
|
Proven antimicrobial efficacy |
|
Complete and continuous cleaning action achieved up to 7 days 11 |
|
Comfort and ease of use |
|
INDICATIONS
All wounds at risk or with signs of local infection, from the debridement stage, including:
- Exuding wounds
- Chronic wounds
- Leg ulcers
- Pressure injuries
- Diabetic foot ulcers
- Long standing acute wounds
CONTRAINDICATIONS
- Known sensitation to silver
- UrgoClean Ag is not suitable for use as a surgical sponge for heavily bleeding wounds
- Do not use UrgoClean Ag in combination with hydrogen peroxide, organomercuric antiseptics or hexamidine
- Do not use on patients undergoing Magnetic Resonance (MRI) examination
PRECAUTIONS
- Treatment with UrgoClean Ag should be carried out under medical supervision.
- Use of this dressing does not negate the need for appropriate systemic anti-bacterial treatment of infected wounds in line with local policy.
- The soft-adherent Silver Healing Matrix (TLC-Ag) of UrgoClean Ag adheres to latex surgical gloves. It is therefore recommended that the dressing be handled carefully, avoiding any contact with the soft-adherent side or using sterile pliers.
- Concomitant use with other local treatments is not recommended.
- Avoid contact with electrodes or conductive gels during electronic measurements, e.g. EEG and ECG.
- Clinicians / Healthcare Professionals should be aware that there are very limited data on prolonged and repeated use of silver containing dressings, particularly in children and neonates.
- In the absence of any specific clinical data, use in pregnant or breast-feeding women, is not recommended.
- Do not use in a hyperbaric chamber.
- Single-use, individual packaging. Re-using a single use dressing may lead to risks of infection. Check that the sterile protector is intact before use.
- Do not re-sterilise.
- For elimination, discard according to current protocol. Discard any unused parts of the dressing.
CUTTING GUIDE
DIRECTIONS FOR USE
WOUND PREPARATION
- Cleanse the wound using saline solution. In the event of prior use of an antiseptic (with the exception of contra-indicated antiseptics) carefully rinse the wound with saline solution before applying the dressing.
- The use of UrgoClean Ag does not dispense with the need for mechanical debridement when required.
- During the desloughing process, the wound may appear to be larger in size. This is due to the effective removal of slough.
DRESSING CHANGES
- UrgoClean Ag dressings should be changed every 1 to 2 days during the wound desloughing phase, then as often as required (up to 7 days) depending on the exudate volume and the clinical condition of the wound.
- The maximal duration of the treatment with UrgoClean Ag is one month.
PRODUCT OPTIONS
| Product Code | Product Size | Units/Box |
|---|---|---|
| 100490 | 6x6cm | 10 |
| 100491 | 10x10cm | 10 |
| 100492 | 15x20cm | 5 |
CLINICAL EVIDENCE
Urgo Ag Range Contact Form
References
- Percival S. L. (2018). Restoring balance: biofilms and wound dressings. Journal of wound care, 27(2), 102-113. https://doi.org/10.12968/jowc.2018.27.2.102
- Desroche N. et al. (2017). Comparison of in vitro anti-biofilm activities of a new poly-absorbent dressing with a silver matrix and a silver containing CMC dressing. Poster EWMA. May, 2017
- Desroche N, et al. (2016). Characterization of the antimicrobial spectrum and anti-biofilm activity of a new silver-containing dressing with poly-absorbent fibres and antimicrobial silver matrix. Poster EWMA. May 2016
- Desroche N., et al. (2017) Evaluation of in vitro anti-biofilm activities of two dressings with poly-absorbent dressing fibres and a DACC coated dressing. Poster EWMA. May 2017
- Percival, S. L., & Suleman, L. (2015). Slough and biofilm: removal of barriers to wound healing by desloughing. Journal of wound care, 24(11), 498-510. https://doi.org/10.12968/jowc.2015.24.11.498
- Dissemond, J., Dietlein, M., Neßeler, I., Funke, L., Scheuermann, O., Becker, E., Thomassin, L., Möller, U., Bohbot, S., & Münter, K. C. (2020). Use of a TLC-Ag dressing on 2270 patients with wounds at risk or with signs of local infection: an observational study. Journal of wound care, 29(3), 162-173. https://doi.org/10.12968/jowc.2020.29.3.162
- Meaume S, Dissemond J, Addala A, et al. Evaluation of two fibrous wound dressings for the management of leg ulcers: results of a European randomised controlled trial (EARTH RCT). J Wound Care. 2014;23(3):105-116. doi:10.12968/jowc.2014.23.3.105
- Kelly J, McGrath A, Wildman S. UrgoClean: a new dressing for desloughing exuding wounds. Br J Community Nurs. 2013;Suppl:S42-S49. doi:10.12968/bjcn.2013.18.sup6.s42
- Study no.S/2003 007/BIOalternatives
- Benbow M, Iosson G. A clinical evaluation of Urgotul to treat acute and chronic wounds. Br J Nurs. 2004;13(2):105-109. doi:10.12968/bjon.2004.13.2.12042
- Dalac S., Sigal L., Addala A., et al Clinical evaluation of a dressing with poly absorbent fibres and a silver matrix for managing chronic wounds at risk of infection: a non comparative trial. J Wound Care, Vol 25, No 9, September 2016
Page updated on 20 May 2024
